subscribeSubscribe
FDA Confirms Para IV Patent Litigation for Suvorexant (Calquence) Tablets

FDA Confirms Para IV Patent Litigation for Suvorexant (Calquence) Tablets
FDA
26 Apr 2024
Share Share
Suvorexant Increases Sleep Time in Patients With Alzheimer Dementia, Insomnia

Suvorexant Increases Sleep Time in Patients With Alzheimer Dementia, Insomnia
M. Meglio NEUROLOGYLIVE
03 Sep 2020
Share Share
Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Merck gets Alzheimer’s label claim for insomnia drug Belsomra
Phil Taylor PMLIVE
05 Feb 2020
Share Share
Experts doubtful of Idorsia’s daridorexant uptake potential in insomnia

Experts doubtful of Idorsia’s daridorexant uptake potential in insomnia
CLINICALTRIALSARENA
27 Jan 2020
Share Share
World first clinical trial commences in alcohol use disorder

World first clinical trial commences in alcohol use disorder
BIOSPECTRUMASIA
28 Oct 2019
Share Share
Trial to test insomnia drug for alcohol use disorder

Trial to test insomnia drug for alcohol use disorder
CLINICALTRIALSARENA
25 Oct 2019
Share Share
Merck’s BELSOMRA® C-IV Meets Primary Efficacy Endpoint in Pha3 Trial

Merck’s BELSOMRA® C-IV Meets Primary Efficacy Endpoint in Pha3 Trial
BUSINESSWIRE
07 May 2019
Share Share
Pharma`s DTC ad spending soars past $5B in 2015

Pharma`s DTC ad spending soars past $5B in 2015
Beth Snyder Bulik FIERCE PHARMA MARKETING
07 Mar 2016
Share Share
Jardiance, Belsomra and Entyvio brand managers share DTC honors with oldsters

Jardiance, Belsomra and Entyvio brand managers share DTC honors with oldsters
Beth Snyder Bulik FIERCE PHARMA MARKETING
29 Feb 2016
Share Share
AbbVie`s Humira repeats, joined by BMS` Opdivo in leading TV spending

AbbVie`s Humira repeats, joined by BMS` Opdivo in leading TV spending
Beth Snyder Bulik FIERCE PHARMA MARKETING
18 Nov 2015
Share Share